Stock-Based Compensation (Details Narrative) - USD ($) |
12 Months Ended | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 12, 2020 |
Aug. 01, 2020 |
Jul. 15, 2020 |
Jul. 14, 2020 |
Jul. 03, 2020 |
Aug. 04, 2019 |
Jul. 23, 2019 |
May 22, 2019 |
Aug. 04, 2018 |
Sep. 14, 2015 |
Jun. 20, 2007 |
Dec. 31, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Jul. 02, 2020 |
Dec. 31, 2018 |
Sep. 14, 2017 |
Sep. 14, 2016 |
|
| Stock options granted to purchase common stock, issued | 33,333 | |||||||||||||||||
| Stock options granted to purchase common stock, outstanding | 1,475,000 | 1,475,000 | 1,308,333 | 1,291,667 | ||||||||||||||
| Stock option vested exercisable term | 5 years | |||||||||||||||||
| Stock options are exercisable price per share | $ 6.60 | |||||||||||||||||
| Number of fully vested option issued | 27,420 | |||||||||||||||||
| Stock price per share | $ 5.6718 | $ 3.65 | $ 3.65 | |||||||||||||||
| Stock options fully vested amount, fair value | $ 189,060 | $ 100,000 | ||||||||||||||||
| Stock based compensation | 1,251,349 | $ 748,655 | ||||||||||||||||
| Total deferred compensation expense for outstanding value of unvested stock options | 894,000 | |||||||||||||||||
| Intrinsic value of exercisable but unexercised in-the-money stock options | $ 747,750 | $ 747,750 | ||||||||||||||||
| Fair market value, per share | $ 3.17 | |||||||||||||||||
| Outstanding stock options to acquire shares of common stock not vested | 150,000 | 150,000 | ||||||||||||||||
| Board of Directors [Member] | ||||||||||||||||||
| Number of warrants outstanding acquire common stock | 166,666 | |||||||||||||||||
| Warrants term, description | September 14, 2020 to September 14, 2025 | |||||||||||||||||
| Closing stock price of warrants | $ 5.40 | |||||||||||||||||
| Collaboration Agreement [Member] | BioPharmaWorks [Member] | ||||||||||||||||||
| Stock price per share | $ 4.0242 | |||||||||||||||||
| Stock options fully vested amount, fair value | $ 670,715 | |||||||||||||||||
| Number of warrants to purchase common stock | 166,666 | |||||||||||||||||
| Number of warrants to purchase common stock per warrant | 83,333 | |||||||||||||||||
| Warrant exercisable term | 5 years | 5 years | ||||||||||||||||
| Warrants exercise price | $ 12.00 | $ 6.00 | ||||||||||||||||
| General and Administrative Expense [Member] | ||||||||||||||||||
| Stock based compensation | $ 31,046 | |||||||||||||||||
| Winson Sze Chun Ho [Member] | ||||||||||||||||||
| Stock options granted to purchase common stock, issued | 33,333 | |||||||||||||||||
| Stock option vested exercisable term | 5 years | |||||||||||||||||
| Stock options are exercisable price per share | $ 1.68 | |||||||||||||||||
| Number of fully vested option issued | 16,667 | 16,667 | ||||||||||||||||
| Fair value of stock options | $ 104,920 | |||||||||||||||||
| Stock price per share | $ 1.5738 | |||||||||||||||||
| Stock options fully vested amount, fair value | $ 101,475 | |||||||||||||||||
| Dr. Yun Yen [Member] | ||||||||||||||||||
| Stock options granted to purchase common stock, issued | 8,333 | 33,333 | ||||||||||||||||
| Stock option vested exercisable term | 5 years | |||||||||||||||||
| Stock options are exercisable price per share | $ 1.68 | |||||||||||||||||
| Number of fully vested option issued | 16,667 | 16,667 | ||||||||||||||||
| Fair value of stock options | $ 104,920 | |||||||||||||||||
| Stock price per share | $ 1.5738 | |||||||||||||||||
| Stock options fully vested amount, fair value | $ 101,475 | |||||||||||||||||
| Dr. Winson Sze Chun Ho [Member] | ||||||||||||||||||
| Stock options granted to purchase common stock, issued | 8,333 | |||||||||||||||||
| Dr. Stephen Forman [Member] | ||||||||||||||||||
| Stock options granted to purchase common stock, issued | 8,333 | |||||||||||||||||
| Dr. Philip Palmedo [Member] | ||||||||||||||||||
| Stock options granted to purchase common stock, issued | 8,333 | |||||||||||||||||
| Eric Forman [Member] | ||||||||||||||||||
| Stock option vested exercisable term | 5 years | |||||||||||||||||
| Stock options are exercisable price per share | $ 6.60 | |||||||||||||||||
| Number of fully vested option issued | 16,667 | |||||||||||||||||
| Stock price per share | $ 5.6718 | |||||||||||||||||
| Stock options fully vested amount, fair value | $ 94,525 | |||||||||||||||||
| Eric Forman [Member] | Employment Agreement [Member] | ||||||||||||||||||
| Stock options granted to purchase common stock, issued | 58,333 | |||||||||||||||||
| Stock option vested exercisable term | 5 years | |||||||||||||||||
| Stock options are exercisable price per share | $ 7.14 | |||||||||||||||||
| Fair value of stock options | $ 400,855 | |||||||||||||||||
| Stock price per share | $ 6.8718 | |||||||||||||||||
| Stock options fully vested amount, fair value | $ 100,214 | |||||||||||||||||
| Stock options description | On July 15, 2020, as amended on August 12, 2020, in connection with the employment agreement entered into with Eric Forman, Mr. Forman was granted options for 58,333 shares of the Company's common stock. The options can be exercised on a cashless basis. The options have a term of five years and an exercise price of $7.14 per share, which was equal to the closing price of the Company's common stock on the grant date. The options vested as to 25% on August 12, 2020, and will vest 25% on each of the first, second and third anniversaries of the grant date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $400,855 ($6.8718 per share), of which $100,214 was attributable to the stock options fully-vested on August 12, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options will be charged to operations ratably from August 12, 2020 through August 12, 2023. During the year ended December 31, 2020, the Company recorded a charge to general and administrative costs in the consolidated statement of operations of $138,926 with respect to these stock options. | |||||||||||||||||
| Eric Forman [Member] | General and Administrative Expense [Member] | ||||||||||||||||||
| Stock based compensation | $ 138,926 | |||||||||||||||||
| Mr. Johnson's [Member] | ||||||||||||||||||
| Stock options granted to purchase common stock, issued | 83,333 | |||||||||||||||||
| Stock option vested exercisable term | 5 years | |||||||||||||||||
| Stock options are exercisable price per share | $ 6.00 | |||||||||||||||||
| Stock price per share | $ 5.2083 | |||||||||||||||||
| Stock options fully vested amount, fair value | $ 434,024 | |||||||||||||||||
| Dr. James Miser [Member] | Employment Agreement [Member] | ||||||||||||||||||
| Stock options granted to purchase common stock, issued | 83,334 | |||||||||||||||||
| Stock option vested exercisable term | 5 years | |||||||||||||||||
| Stock options are exercisable price per share | $ 7.14 | |||||||||||||||||
| Fair value of stock options | $ 572,650 | |||||||||||||||||
| Stock price per share | $ 6.8718 | |||||||||||||||||
| Stock options fully vested amount, fair value | $ 143,163 | |||||||||||||||||
| Stock options description | Dr. Miser was granted options for 83,334 shares of the Company's common stock. The options can be exercised on a cashless basis. The options have a term of five years and an exercise price of $7.14 per share, which was equal to the closing price of the Company's common stock on the effective date of the employment agreement. The options vested as to 25% on the effective date, and will vest 25% on each of the first, second and third anniversaries of the effective date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $572,650 ($6.8718 per share), of which $143,163 was attributable to the stock options fully-vested on August 1, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options will be charged to operations ratably from August 1, 2020 through August 1, 2023. During the year ended December 31, 2020, the Company recorded a charge to general and administrative costs in the consolidated statement of operations of $202,782 with respect to these stock options. | |||||||||||||||||
| Dr. James Miser [Member] | General and Administrative Expense [Member] | ||||||||||||||||||
| Stock based compensation | $ 202,782 | |||||||||||||||||
| Robert N. Weingarten [Member] | Employment Agreement [Member] | ||||||||||||||||||
| Stock options granted to purchase common stock, issued | 58,333 | |||||||||||||||||
| Stock option vested exercisable term | 5 years | |||||||||||||||||
| Stock options are exercisable price per share | $ 7.14 | |||||||||||||||||
| Fair value of stock options | $ 400,855 | |||||||||||||||||
| Stock price per share | $ 6.8718 | |||||||||||||||||
| Stock options fully vested amount, fair value | $ 100,214 | |||||||||||||||||
| Stock options description | On August 12, 2020, in connection with the employment agreement entered into with Robert N. Weingarten, Mr. Weingarten was granted options for 58,333 shares of the Company's common stock. The options can be exercised on a cashless basis. The options have a term of five years and an exercise price of $7.14 per share, which was equal to the closing price of the Company's common stock on the grant date. The options vested as to 25% on August 12, 2020, and will vest 25% on each of the first, second and third anniversaries of the grant date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $400,855 ($6.8718 per share), of which $100,214 was attributable to the stock options fully-vested on August 12, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options will be charged to operations ratably from August 12, 2020 through August 12, 2023. During the year ended December 31, 2020, the Company recorded a charge to general and administrative costs in the consolidated statement of operations of $138,926 with respect to these stock options. | |||||||||||||||||
| Robert N. Weingarten [Member] | General and Administrative Expense [Member] | ||||||||||||||||||
| Stock based compensation | $ 138,926 | |||||||||||||||||
| 2007 Stock Compensation Plan [Member] | ||||||||||||||||||
| Stock options granted to purchase common stock, issued | 208,333 | |||||||||||||||||
| Stock options granted to purchase common stock, outstanding | 208,333 | 208,333 | ||||||||||||||||
| 2007 Stock Compensation Plan [Member] | Maximum [Member] | ||||||||||||||||||
| Number of restricted stock issued | 416,667 | |||||||||||||||||
| 2020 Stock Incentive Plan [Member] | Maximum [Member] | ||||||||||||||||||
| Number of restricted stock issued | 2,333,333 | |||||||||||||||||